TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35580898

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (HFNO)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Conventional oxygen therapy (COT)
Number of subjects: 364
Study: 33410360

Group type: EXPERIMENTAL
Intervention: Direct superior approach (DSA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Posterolateral approach (PL)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both DSA and PL
Number of subjects: 45
Study: 33460256

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment (SBP < 120 mm Hg)
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard blood pressure treatment (SBP < 140 mm Hg)
Number of subjects: 9361
Study: 34081137

Group type: EXPERIMENTAL
Intervention: Smartphone app intervention for 6 months
Number of subjects: 204

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Smartphone app intervention for participants with HbA1c levels of 8% or higher
Number of subjects: 204
Study: 32009299

Group type: EXPERIMENTAL
Intervention: Topical TFB application
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo application
Number of subjects: 15
Study: 33496621

Group type: EXPERIMENTAL
Intervention: RCTs including clinical patients
Number of subjects: 212

Group type: COMPARATOR
Intervention: Abstracts meeting CONSORT recommendations for title, participant eligibility criteria, primary outcome, randomization technique, blinding, numbers analyzed, primary outcome results, and harms to participants
Number of subjects: 212

Group type: COMPARATOR
Intervention: Overall reporting quality of abstracts
Number of subjects: 212
Study: 32084526

Group type: EXPERIMENTAL
Intervention: Liver-directed concurrent chemoradiotherapy (LD-CCRT) and sequential sorafenib treatment (400 mg, twice daily)
Number of subjects: 47
Study: 35289183

Group type: EXPERIMENTAL
Intervention: Vitamin C (200 mg/kg) administered intravenously for 30 minutes after return of spontaneous circulation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study: 34793552

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 16676

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 16676

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 16676

Group type: COMPARATOR
Intervention: Age
Number of subjects: 16676

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 16676
Study: 32192454

Group type: EXPERIMENTAL
Intervention: Living in homes with chimney
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Living in homes with eaves space
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Living in homes with improved cookstove
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Cow dung fuel use
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Child spending time near stove during cooking
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Presence of extra indoor burning events
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Frequent cooking of meals
Number of subjects: 5830
Study: 33573391

Group type: EXPERIMENTAL
Intervention: Recruitment strategies for healthcare providers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multimodal recruitment strategies
Number of subjects: 0
Study: 32792712

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no TES)
Number of subjects: 48
Study: 34266522

Group type: EXPERIMENTAL
Intervention: Lactase treatment (4 drops of lactase additive, 180 mg added into preterm formula or breast milk)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (placebo, oral probiotics at half an hour after feeding, and abdominal massage)
Number of subjects: 60
Study: 34366180

Group type: EXPERIMENTAL
Intervention: Digital media-based hand therapy (self-directed, 12-week protocol)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Traditional hand therapy (12-week protocol)
Number of subjects: 49
Study: 34747584

Group type: EXPERIMENTAL
Intervention: Pavlovian conditioning intervention (Progressive Muscle Relaxation paired with fruit intake)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Active explicitly unpaired control group (Progressive Muscle Relaxation and fruit intake not temporally paired)
Number of subjects: 100
Study: 36245145

Group type: EXPERIMENTAL
Intervention: Galnobax 14% BID
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Galnobax 20% BID
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Galnobax 20% OD + vehicle
Number of subjects: 4

Group type: COMPARATOR
Intervention: Vehicle BID
Number of subjects: 4
Study: 33897958

Group type: EXPERIMENTAL
Intervention: Trait-based (TB) scoring tool
Number of subjects: 10

Group type: COMPARATOR
Intervention: Element-based (EB) scoring tool
Number of subjects: 10
Study: 32376812

Group type: EXPERIMENTAL
Intervention: Smartphone app-based walking exercise program (12 weeks duration, includes education via app, 12 SMS, 1 individual counseling)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Smartphone app-based walking exercise program
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 61
Study: 34549853

Group type: EXPERIMENTAL
Intervention: P11-4
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Fluoridate toothpaste (FT)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Fluoridate bioactive glass toothpaste (BT)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: P11-4 + CPP-ACP
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: P11-4 + BT
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control
Number of subjects: 154
Study: 34818617

Group type: EXPERIMENTAL
Intervention: Anodal HD-tDCS over parietal cortex and cerebellum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cathodal HD-tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 35029045

Group type: EXPERIMENTAL
Intervention: vilobelimab plus best supportive care
Number of subjects: 30

Group type: COMPARATOR
Intervention: best supportive care only
Number of subjects: 30
Study: 34828790

Group type: EXPERIMENTAL
Intervention: Combined Music Therapy (MT) and Skin-to-Skin Care (SSC)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Skin-to-Skin Care (SSC) alone
Number of subjects: 68
Study: 35086206

Group type: EXPERIMENTAL
Intervention: 2.2 mm clear corneal incision
Number of subjects: 130

Group type: COMPARATOR
Intervention: 2.8 mm clear corneal incision
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study: 33839489

Group type: EXPERIMENTAL
Intervention: Nasal betamethasone drops (3 times daily for a maximum of one month)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo (9% NaCl drops, similar dosage to betamethasone)
Number of subjects: 276
Study: 33413936

Group type: EXPERIMENTAL
Intervention: Bilateral internal thoracic arteries (BITAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single internal thoracic arteries (SITAs)
Number of subjects: 0
Study: 32911009

Group type: EXPERIMENTAL
Intervention: SDA treatment using resin bonded bridgework (RBB)
Number of subjects: 89

Group type: COMPARATOR
Intervention: RDPs (removable dental prostheses)
Number of subjects: 89
Study: 35590253

Group type: EXPERIMENTAL
Intervention: IL‐1α ‐889C/T (rs1800587) polymorphism
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: IL‐1β ‐511C > T (rs16944) polymorphism
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: TNFα ‐308G > A (rs1800629) polymorphism
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: TNFα ‐238G > A (rs361525) polymorphism
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: IL‐6 ‐174G > C (rs1800795) polymorphism
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: IL‐6 ‐572G > C (rs1800796) polymorphism
Number of subjects: 54
Study: 33386149

Group type: EXPERIMENTAL
Intervention: Causal methylation-mRNA regulation chains identified through summary statistic data-based Mendelian randomization (SMR) analysis.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal inference test (CIT) performed on methylation-mRNA pairs.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SYNGR1 expression in peripheral blood mononuclear cells.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylations located in CpG Islands overlapping promoters in the 5′ region of the genes.
Number of subjects: 0
Study: 32664074

Group type: EXPERIMENTAL
Intervention: Health belief model-based interventions
Number of subjects: 346

Group type: COMPARATOR
Intervention: Conventional breastfeeding guidance
Number of subjects: 346
Study: 35903763

Group type: EXPERIMENTAL
Intervention: Good Enough Sex (GES)‐based, couple‐centered group counseling
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 35723714

Group type: EXPERIMENTAL
Intervention: Adjunctive botanical patch applications (3 times on day 0 and once daily on days 1-6)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No additional therapy (SRP alone, control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Adjunctive botanical patch applications
Number of subjects: 80
Study: 36053757

Group type: EXPERIMENTAL
Intervention: 7.5 mg MTX subcutaneously
Number of subjects: 0

Group type: COMPARATOR
Intervention: 8 mg MTX orally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MJK101 (subcutaneous MTX)
Number of subjects: 0
Study: 34649864

Group type: EXPERIMENTAL
Intervention: Therapeutic heparin
Number of subjects: 465

Group type: COMPARATOR
Intervention: Prophylactic heparin
Number of subjects: 465
Study: 35775212

Group type: EXPERIMENTAL
Intervention: Tailored Counseling and Navigation (TCN)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Tailored Print (TP)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 641
Study: 33041277

Group type: EXPERIMENTAL
Intervention: Intraoral scanner (IOS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Extraoral scanner (EOS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Monolithic lithium disilicate ceramic (LM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Monolithic zirconia (ZM)
Number of subjects: 40
Study: 36071341

Group type: EXPERIMENTAL
Intervention: Financial incentives to promote service engagement
Number of subjects: 34
Study: 33820463

Group type: EXPERIMENTAL
Intervention: Plasma GH levels measured using a competitive homologous enzyme-linked immunosorbent assay.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ultradian (12 h) and 24 h rhythms of plasma GH.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Mapping of acrophases of GH.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Gonadosomatic index (GSI) of male catfish.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Comparison of plasma GH Mesors and acrophases between male and female catfish.
Number of subjects: 240
Study: 36030801

Group type: EXPERIMENTAL
Intervention: Midwife group (sublingual misoprostol 400 μg every 3 hours for up to five doses)
Number of subjects: 1191

Group type: COMPARATOR
Intervention: Physician group (sublingual misoprostol 400 μg every 3 hours for up to five doses)
Number of subjects: 1191
Study: 34182933

Group type: EXPERIMENTAL
Intervention: AutoFlow
Number of subjects: 80

Group type: COMPARATOR
Intervention: VCV
Number of subjects: 80
Study: 35322892

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 64

Group type: COMPARATOR
Intervention: Endoscopic band ligation (EBL)
Number of subjects: 64
Study: 32086373

Group type: EXPERIMENTAL
Intervention: Abstinence-contingent wage supplements
Number of subjects: 91

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 91
Study: 35856049

Group type: EXPERIMENTAL
Intervention: Oral stimulation program
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Routine newborn procedures (Control)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Multistimulation (combined oromotor and tactile stimulation)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Oromotor stimulation
Number of subjects: 44
Study: 33380362

Group type: EXPERIMENTAL
Intervention: Vial-and-syringe (V–S)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Accessorized prefilled syringe (APFS)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Autoinjector (AI)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 315
Study: 35260960

Group type: EXPERIMENTAL
Intervention: BPA plus education
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: BPA only
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: BPA plus education (phase 2)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: BPA only (phase 2)
Number of subjects: 22
Study: 33846362

Group type: EXPERIMENTAL
Intervention: Machine learning methods (extremely randomized trees) for predicting postpartum depression
Number of subjects: 4313

Group type: EXPERIMENTAL
Intervention: Machine learning methods (extremely randomized trees) for predicting postpartum depression among women without previous depression
Number of subjects: 4313
Study: 36345347

Group type: EXPERIMENTAL
Intervention: Intravenous sildenafil dosed every 8 hours for up to 34 days at doses of 0.125, 0.5, and 1 mg/kg/dose in cohorts 1, 2, and 3, respectively.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enteral sildenafil dosed every 8 hours for up to 34 days at doses double the IV doses.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 0
Study: 32422538

Group type: EXPERIMENTAL
Intervention: CBT4CBT (computer-delivered CBT) plus brief monitoring
Number of subjects: 205

Group type: COMPARATOR
Intervention: In-person CBT
Number of subjects: 205

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 205

Group type: COMPARATOR
Intervention: CBT4CBT plus TAU
Number of subjects: 205

Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 205
Study: 36287562

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet intervention (target <40 net grams of carbohydrates during the first 3 months; <60 net grams for months 3 to 6) with dietary counseling
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 150
Study: 33444529

Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionation (42.7 Gy in seven fractions, 3 days per week for 2.5 weeks)
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Conventional fractionation (78.0 Gy in 39 fractions, 5 days per week for 8 weeks)
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionation
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Conventional fractionation
Number of subjects: 1180
Study: 35815354

Group type: EXPERIMENTAL
Intervention: BFF MDI (budesonide/formoterol fumarate dihydrate metered dose inhaler) 320/10 µg with a spacer
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BUD/FORM DPI (budesonide/formoterol fumarate dry powder inhaler) 320/9 µg
Number of subjects: 30
Study: 32746598

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia (group CS)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia (group DS)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia (group CW)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia (group DW)
Number of subjects: 160
Study: 36385459

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided internal jugular vein (IJV) approach
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided axillary vein (AV) approach
Number of subjects: 210
Study: 32331356

Group type: EXPERIMENTAL
Intervention: Real-time video communication software
Number of subjects: 430

Group type: COMPARATOR
Intervention: Telephone
Number of subjects: 430
Study: 35426903

Group type: EXPERIMENTAL
Intervention: SMS+ERS
Number of subjects: 0

Group type: COMPARATOR
Intervention: ERS alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study: 33778945

Group type: EXPERIMENTAL
Intervention: 36 or 54 mg of extended-release methylphenidate
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (after gradual withdrawal from methylphenidate)
Number of subjects: 94
Study: 36122564

Group type: EXPERIMENTAL
Intervention: Self-initiated exercise
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Relaxation techniques
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Dietary or nutritional adjustments
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Adoption of at least one lifestyle factor
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Adoption of lifestyle factors in all three domains
Number of subjects: 115
Study: 32141724

Group type: EXPERIMENTAL
Intervention: Neuroscience-informed auditory training (AT) exercises
Number of subjects: 84
Study: 33825677

Group type: EXPERIMENTAL
Intervention: Educational intervention with follow-up visits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 0
Study: 33933265

Group type: EXPERIMENTAL
Intervention: Autologous platelet gel application in tubularized incised plate (TIP) repair
Number of subjects: 30

Group type: COMPARATOR
Intervention: TIP repair without autologous platelet gel
Number of subjects: 30
Study: 32016111

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (12 sessions)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Extracorporeal magnetic innervation (12 sessions)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no therapeutic intervention)
Number of subjects: 128
Study: 32447370

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine
Number of subjects: 913

Group type: COMPARATOR
Intervention: Control
Number of subjects: 913

Group type: EXPERIMENTAL
Intervention: Baseline carriage density
Number of subjects: 913
Study: 35830848

Group type: EXPERIMENTAL
Intervention: Cinnamon infusion (2 g, Cinnamomum sp.)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 21
Study: 33016219

Group type: EXPERIMENTAL
Intervention: Perceived social support via belonging affirmation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No perceived social support
Number of subjects: 0
Study: 36318788

Group type: EXPERIMENTAL
Intervention: RMST-based decision aid (n=49)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional decision aid (n=53)
Number of subjects: 102
Study: 33665813

Group type: EXPERIMENTAL
Intervention: ZnO‐NP‐coated socks
Number of subjects: 148

Group type: COMPARATOR
Intervention: Uncoated socks
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Both groups (ZnO‐NP-coated and uncoated socks)
Number of subjects: 148
Study: 32212012

Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin at a prophylactic dose (SHPD) - enoxaparin 4000 U/day
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: SHPD reduction/discontinuation
Number of subjects: 383
Study: 35285398

Group type: COMPARATOR
Intervention: Virtual home visits
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: In-person home visits
Number of subjects: 30
Study: 34312872

Group type: EXPERIMENTAL
Intervention: Early orthodontic therapy (OT) at 4 weeks post surgery
Number of subjects: 43

Group type: COMPARATOR
Intervention: Late orthodontic therapy (OT) at 6 months post surgery
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Early orthodontic therapy (OT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Late orthodontic therapy (OT)
Number of subjects: 43
Study: 35192411

Group type: EXPERIMENTAL
Intervention: Selumetinib 75 mg orally twice daily for approximately 5 weeks
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Selumetinib
Number of subjects: 400
Study: 33522954

Group type: EXPERIMENTAL
Intervention: Healthy low-carbohydrate diet (< 40 g of net carbohydrates for the first 3 months and < 40 to 60 net grams for months 3 to 6)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Healthy low-carbohydrate diet
Number of subjects: 150
Study: 616038894

Group type: EXPERIMENTAL
Intervention: Lutein and zeaxanthin supplementation
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 5
Study: 35575839

Group type: EXPERIMENTAL
Intervention: 8-week distance-delivered social skills program, sessions offered twice a week for 90 min
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 24
Study: 33150640

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT‐E)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for Eating Disorders (IPT‐ED)
Number of subjects: 130
Study: 35688173

Group type: EXPERIMENTAL
Intervention: Nivolumab (240 mg IV every 2 weeks) plus Cabozantinib (40 mg orally once daily)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Sunitinib (50 mg orally once daily)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Nivolumab plus Cabozantinib
Number of subjects: 651

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 651
Study: 34331676

Group type: EXPERIMENTAL
Intervention: Probiotics used concurrently with antibiotics (Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis) for 1 week
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Probiotics used after antibiotics for 1 week
Number of subjects: 55

Group type: COMPARATOR
Intervention: Antibiotic treatment (piperacillin–tazobactam) for 1 week
Number of subjects: 55

Group type: COMPARATOR
Intervention: No intervention (antibiotic therapy only)
Number of subjects: 55
Study: 32727497

Group type: EXPERIMENTAL
Intervention: Pelvic bone marrow sparing intensity modulated radiotherapy (PBMS‐IMRT)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (weekly cisplatin with IMRT)
Number of subjects: 164
Study: 36436774

Group type: EXPERIMENTAL
Intervention: Biplane thrombectomy
Number of subjects: 197

Group type: COMPARATOR
Intervention: Monoplane thrombectomy
Number of subjects: 197
Study: 33380155

Group type: EXPERIMENTAL
Intervention: Palliative care intervention (neuropalliative care consultations with a multidisciplinary palliative team)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 103